Jane Street
HARP

Jane Street’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Jane Street’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,673
Closed -$11.9K – 9686
2023
Q2 		$11.9K Buy
+1,673
New +$11.6K ﹤0.01% 8418
2021
Q3 		– Sell
-1,385
Closed -$192K – 11020
2021
Q2 		$192K Buy
+1,385
New +$264K ﹤0.01% 8863

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Jane Street's HARP Position: Q3 2023 in Review

Jane Street sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 1,673 shares — an estimated $11.9K sold.

Jane Street first reported a position in HARP in Q2 2021 and held it in 2 quarters. The position peaked at $192K in Q2 2021. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • Jane Street reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 1,673 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $11.9K.
  • Jane Street first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Jane Street's Harpoon Therapeutics, Inc. Common Stock position peaked at $192K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.